Sökning: onr:"swepub:oai:lup.lub.lu.se:4cf2662d-c2e8-4e7d-b83e-1b1a82019b73" > Cost-Effectiveness ...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04254naa a2200505 4500 | |
001 | oai:lup.lub.lu.se:4cf2662d-c2e8-4e7d-b83e-1b1a82019b73 | |
003 | SwePub | |
008 | 160401s2014 | |||||||||||000 ||eng| | |
024 | 7 | a https://lup.lub.lu.se/record/46145182 URI |
024 | 7 | a https://doi.org/10.1016/j.jval.2014.03.17212 DOI |
040 | a (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Hoogendoorn, Martine4 aut |
245 | 1 0 | a Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease: Cross-Model Comparison of Hypothetical Treatment Scenarios |
264 | 1 | b Elsevier BV,c 2014 |
338 | a electronic2 rdacarrier | |
520 | a Objectives To compare different chronic obstructive pulmonary disease (COPD) cost-effectiveness models with respect to structure and input parameters and to cross-validate the models by running the same hypothetical treatment scenarios. Methods COPD modeling groups simulated four hypothetical interventions with their model and compared the results with a reference scenario of no intervention. The four interventions modeled assumed 1) 20% reduction in decline in lung function, 2) 25% reduction in exacerbation frequency, 3) 10% reduction in all-cause mortality, and 4) all these effects combined. The interventions were simulated for a 5-year and lifetime horizon with standardization, if possible, for sex, age, COPD severity, smoking status, exacerbation frequencies, mortality due to other causes, utilities, costs, and discount rates. Furthermore, uncertainty around the outcomes of intervention four was compared. Results Seven out of nine contacted COPD modeling groups agreed to participate. The 5-year incremental cost-effectiveness ratios (ICERs) for the most comprehensive intervention, intervention four, was €17,000/quality-adjusted life-year (QALY) for two models, €25,000 to €28,000/QALY for three models, and €47,000/QALY for the remaining two models. Differences in the ICERs could mainly be explained by differences in input values for disease progression, exacerbation-related mortality, and all-cause mortality, with high input values resulting in low ICERs and vice versa. Lifetime results were mainly affected by the input values for mortality. The probability of intervention four to be cost-effective at a willingness-to-pay value of €50,000/QALY was 90% to 100% for five models and about 70% and 50% for the other two models, respectively. Conclusions Mortality was the most important factor determining the differences in cost-effectiveness outcomes between models. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi0 (SwePub)303012 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Health Care Service and Management, Health Policy and Services and Health Economy0 (SwePub)303012 hsv//eng |
653 | a COPD | |
653 | a cost-effectiveness | |
653 | a model | |
653 | a validation | |
700 | 1 | a Feenstra, Talitha L4 aut |
700 | 1 | a Asukai, Yumi4 aut |
700 | 1 | a Borg, Sixtenu Lund University,Lunds universitet,Hälsoekonomi,Forskargrupper vid Lunds universitet,Health Economics,Lund University Research Groups4 aut0 (Swepub:lu)med-sxb |
700 | 1 | a Hansen, Ryan N4 aut |
700 | 1 | a Jansson, Sven-Arne4 aut |
700 | 1 | a Samyshkin, Yevgeniy4 aut |
700 | 1 | a Wacker, Margarethe4 aut |
700 | 1 | a Briggs, Andrew H4 aut |
700 | 1 | a Lloyd, Adam4 aut |
700 | 1 | a Sullivan, Sean D4 aut |
700 | 1 | a Rutten-van Mölken, Maureen P M H4 aut |
710 | 2 | a Hälsoekonomib Forskargrupper vid Lunds universitet4 org |
773 | 0 | t Value in Healthd : Elsevier BVg 17:5, s. 525-536q 17:5<525-536x 1098-3015 |
856 | 4 | u https://portal.research.lu.se/files/1591123/4729884.pdfx primaryx freey FULLTEXT |
856 | 4 | u http://www.ncbi.nlm.nih.gov/pubmed/25128045?dopt=Abstracty FULLTEXT |
856 | 4 | u http://dx.doi.org/10.1016/j.jval.2014.03.1721y FULLTEXT |
856 | 4 | u http://www.valueinhealthjournal.com/article/S1098301514017823/pdf |
856 | 4 8 | u https://lup.lub.lu.se/record/4614518 |
856 | 4 8 | u https://doi.org/10.1016/j.jval.2014.03.1721 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.